Session Chair Profile
International Business Leader, Roche Molecular Systems, Inc.
Allison Ballmer is an International Business Leader at Roche Sequencing, focused on advancing Next Generation Sequencing platforms into the clinic. Prior to joining Roche, Ballmer led Global Marketing and Commercialization for Swiss-based Molecular Diagnostics arm of Biocartis. She held various Business Development and Commercial leadership roles in Molecular Diagnostics with a particular emphasis in Oncology. She began her career in Cancer Diagnostics holding leadership roles in Quality, Regulatory and Operations Management. Ms Ballmer serves on the Advisory Board of Techbridge Girls, a non-profit advancing girls and underrepresented minorities in STEM. She earned her B.S. in Mechanical Engineering from Virginia Tech and Marketing certifications from Cornell University. She is a certified practitioner of Internal Family Systems Therapy and enjoys mentoring and coaching in her free time.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Emerging NGS technologies promise to revolutionize applications in the clinic. They are continuously becoming more affordable, yet the requirements for high accuracy, speed, and better reliability remain. This panel will focus on the newest advancements and the technical challenges they encounter to advancing genomics into the clinic, as well as the requirements needed to optimize patient care.